Consistent with previous findings (15, 17, 22), we have confirmed upregulation of several inflammatory mediators, including those modulated by NLRP2, namely Il6, Cxcl1 and Cxcl5 at early and late stages of the kidney disease. Here, IL6 is linked to kidney disorder.